FDA approves adalimumab-bwwd biosimilar (Hadlima) in high-concentration formAugust 17, 2022PediatricsGastroenterologyDermatologyRheumatology
Biosimilar-to-biosimilar switches deemed safe and effective, systematic review revealsAugust 15, 2022PediatricsGastroenterologyMusculoskeletal DisordersRare DiseasesDermatologyRheumatology
Study suggests psoriasis and PsA are underdiagnosed in underserved groupsAugust 12, 2022RheumatologyDermatology
In RA, tofacitinib shows higher infection rate than TNF inhibitorsAugust 11, 2022RheumatologyInfectious Diseases
Stopping JIA drugs? Many can regain control after a flareAugust 10, 2022PediatricsRare DiseasesMusculoskeletal DisordersRheumatology
Ustekinumab becomes second biologic approved for PsA in kidsAugust 3, 2022PediatricsRare DiseasesMusculoskeletal DisordersRheumatology
FDA approves belimumab for children with lupus nephritisJuly 28, 2022PediatricsRare DiseasesRheumatologyNephrology
Vitamin D supplements do not lower risk of fracturesJuly 28, 2022Preventive CareRheumatologyMusculoskeletal Disorders
Questionnaire for patients with psoriasis might identify risk of axial involvementJuly 26, 2022DermatologyRheumatology
NAFLD strongly correlated with psoriasis, PsA; risk linked to severityJuly 20, 2022DermatologyGastroenterologyRheumatology
Methotrexate’s impact on COVID-19 vaccination: New insights madeJuly 19, 2022COVID-19 UpdatesRheumatologyDermatologyVaccines
Physicians urged to write indications on drug scripts as methotrexate users face new barriers with SCOTUS decisionJuly 13, 2022RheumatologyWomen's HealthMixed Topics
